Colleen Sjogren
CIK: 0002017751
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NUVB
Nuvation Bio Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Feb 27, 2026NUVB
Nuvation Bio Inc.
Award(A)DirectStock Option (Right to Buy)
748.1K shares- - Jun 16, 2025NUVB
Nuvation Bio Inc.
Purchase(P)Direct50K shares at avg. $1.81$90K - Feb 28, 2025NUVB
Nuvation Bio Inc.
Award(A)DirectStock Option (Right to Buy)
500K shares-
1-3 of 3 transactions
About Sjogren Colleen
Sjogren Colleen (SEC CIK 0002017751) files insider reports with the SEC as Chief Commercial Officer of Nuvation Bio Inc. (NUVB).
Signal8 holds 3 ownership filings by Sjogren Colleen, all Form 4s, filed between Mar 4, 2025 and Mar 3, 2026. Those filings report 3 transactions, from Feb 28, 2025 to Feb 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sjogren Colleen's filings is in NEW YORK, NY.
Recent filings by Sjogren Colleen
Other insiders filing for Nuvation Bio Inc. (NUVB)
- Hattersley Gary, CHIEF SCIENTIFIC OFFICER
- Sauvage Philippe, Chief Financial Officer
- Markel Stacy, CHIEF PEOPLE OFFICER
- Wentworth Kerry, CHIEF REGULATORY OFFICER
- Mashal Robert, Director
- VERNON W ANTHONY, Director